AEOVIAN PHARMACEUTICALS
Aeovian Pharmaceuticals is a San Francisco Bay Area-based biopharmaceutical company aiming to discover, develop, and commercialize innovative therapeutics for the treatment of rare and age-related diseases. The company is developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress. Aeovian Pharmaceuticals was founded in 2012.
AEOVIAN PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.aeovian.com
Total Employee:
1+
Status:
Active
Total Funding:
87 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Atea Pharmaceuticals
Atea Pharmaceuticals focuses on the discovery and development of next-generation therapeutics for severe human viral infections.
Exelixis
Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Idorsia
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Santhera Pharmaceuticals
Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
venBio Partners
venBio Partners investment in Series A - Aeovian Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series A - Aeovian Pharmaceuticals
Evotec
Evotec investment in Series A - Aeovian Pharmaceuticals
b2venture
b2venture investment in Series A - Aeovian Pharmaceuticals
Apollo Health Ventures
Apollo Health Ventures investment in Series A - Aeovian Pharmaceuticals
Hevolution
Hevolution investment in Series A - Aeovian Pharmaceuticals
Evotec
Evotec investment in Series A - Aeovian Pharmaceuticals
Apollo Health Ventures
Apollo Health Ventures investment in Series A - Aeovian Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series A - Aeovian Pharmaceuticals
venBio Partners
venBio Partners investment in Series A - Aeovian Pharmaceuticals
Official Site Inspections
http://www.aeovian.com Semrush global rank: 8.98 M Semrush visits lastest month: 445
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Aeovian Pharmaceuticals"
Aeovian Pharmaceuticals Inc.
Mar 28, 2024 Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway. top of page. Home. About. Our Team. Our Board. Our Advisors. Contact. …See details»
Aeovian Pharmaceuticals - Crunchbase Company …
Aeovian Pharmaceuticals is a San Francisco Bay Area-based biopharmaceutical company aiming to discover, develop, and commercialize innovative therapeutics for the treatment of rare and age-related diseases. The company is …See details»
Aeovian Pharmaceuticals - Crunchbase Company Profile & Funding
Aeovian Pharmaceuticals is located in Walnut Creek, California, United States. Who invested in Aeovian Pharmaceuticals? Aeovian Pharmaceuticals is funded by FJ Labs. When was the last …See details»
John Kincaid - Aeovian NEW
Mr. Kincaid joined Aeovian in March 2020 as Chief Scientific Officer. He brings 25 years of drug discovery experience where his teams have led several compounds into clinical trials. He is an …See details»
Aeovian Pharmaceuticals - LinkedIn
Aeovian Pharmaceuticals | 1,073 followers on LinkedIn. Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore ...See details»
Aeovian Pharmaceuticals - Overview, News & Similar companies
Mar 28, 2024 View Aeovian Pharmaceuticals (www.aeovian.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN …
Mar 28, 2024 Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality …See details»
Buck-Founded Aeovian Pharmaceuticals doses first …
Mar 28, 2024 Aeovian also raises $50M to advance novel science. Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potentially inhibit the mTORC1 pathway, …See details»
Aeovian Pharmaceuticals - Funding, Financials, Valuation & Investors
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases. Search Crunchbase. ... How much funding has …See details»
AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN …
Mar 28, 2024 Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potently inhibit the mTORC1 pathway, today …See details»
JUSTIN GOVER - Aeovian NEW
From 2018-2021, Mr. Gover served on the Board of Directors of the Biotechnology Innovation Organization (BIO). Mr. Gover served as CEO and a Board Director of GW since the …See details»
Aeovian Pharmaceuticals - Craft
Aeovian Pharmaceuticals is a biopharmaceutical company specializing in therapeutics for the treatment of rare and age-related diseases. It develops selective modulators of the mTORC1 …See details»
AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN …
Mar 28, 2024 Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potently inhibit the mTORC1 pathway, today …See details»
Aeovian Pharmaceuticals Company Profile 2024: Valuation
Aeovian Pharmaceuticals General Information Description. Developer of innovative therapeutics designed to treat rare and age-related diseases. The company's therapeutics address the …See details»
Davis Ryman - Aeovian NEW
Dr Ryman is a neurologist and geneticist by training, and joined Aeovian in November 2022 as Chief Medical Officer. Prior to joining, he was most recently Chief Medical Officer of Levo …See details»
Hevolution Foundation Announces $20 million Impact Investment …
Boston, 28 March 2024: Hevolution Foundation announced its first life science impact investment of $20 million to help Aeovian Pharmaceuticals advance its innovative platform of selective …See details»
Aeovian raises $37 million for mTORC1 inhibitors
Oct 12, 2019 Aeovian’s first program will inhibit mTORC1 to treat a nervous system disease, but the firm later plans antiaging studies. Chemical & Engineering News. ISSN 0009-2347.See details»
Allison J. Hulme | Aeovian NEW
Dr. Hulme joined Aeovian in January 2020 as CEO, President and Board Member, bringing with her 30 years of experience in drug development and commercialization. Prior to this, she was …See details»
AV-078 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 About Aeovian Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular …See details»
William Greene | Aeovian NEW
Dr. William Greene’s leadership positions have included founder, biotechnology executive, investor, and clinician. As CEO, he built Iconic Therapeutics through discovery, clinical …See details»